Gastroenterology Research and Practice

Splanchnic Vein Thrombosis: Etiology, Diagnosis, and Treatment


Status
Published

Lead Editor

1Fourth Military Medical University, Xi'an, China

2Catholic University, Rome, Italy

3University Hospital of Padua, Padua, Italy

4Xuzhou Medical College, Xuzhou, China

5Ospedale Niguarda Cà Granda, Milano, Italy


Splanchnic Vein Thrombosis: Etiology, Diagnosis, and Treatment

Description

Splanchnic vein thrombosis mainly includes portal vein thrombosis, mesenteric vein thrombosis, and Budd-Chiari syndrome, which often result in lethal complications. Recent advances in the diagnosis and treatment of splanchnic vein thrombosis have greatly improved the prognosis of the patients. However, the current recommendations for the treatment strategy are still based on the expert opinions and results of low-quality studies.

We invite the researchers to contribute original research articles and review articles to explore the etiology, diagnosis, and treatment of portal vein thrombosis, mesenteric vein thrombosis, and Budd-Chiari syndrome. We are particularly interested in high-quality systematic reviews and meta-analyses in this field.

Potential topics include, but are not limited to:

  • Epidemiology and clinical significance of portal vein thrombosis in liver cirrhosis
  • Management of portal vein thrombosis after abdominal and pelvic surgery
  • Pathogenesis of splanchnic vein thrombosis, especially myeloproliferative neoplasms and inherited thrombophilia
  • Imaging diagnosis of splanchnic vein thrombosis
  • Treatment of splanchnic vein thrombosis, especially anticoagulation therapy, thrombolysis, transjugular intrahepatic portosystemic shunt, Rex shunt, and liver transplantation

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 506136
  • - Editorial

Splanchnic Vein Thrombosis: Etiology, Diagnosis, and Treatment

Xingshun Qi | Valerio De Stefano | ... | Andrea Mancuso
  • Special Issue
  • - Volume 2015
  • - Article ID 807865
  • - Research Article

Association between JAK2 rs4495487 Polymorphism and Risk of Budd-Chiari Syndrome in China

Peijin Zhang | Yanyan Zhang | ... | Zhaojun Lu
  • Special Issue
  • - Volume 2015
  • - Article ID 101029
  • - Review Article

Imaging Diagnosis of Splanchnic Venous Thrombosis

S. Rajesh | Amar Mukund | Ankur Arora
  • Special Issue
  • - Volume 2015
  • - Article ID 810851
  • - Clinical Study

Systemic Venous Inflow to the Liver Allograft to Overcome Diffuse Splanchnic Venous Thrombosis

Cristian Lupascu | Tom Darius | ... | Jan Lerut
  • Special Issue
  • - Volume 2015
  • - Article ID 620217
  • - Clinical Study

Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

Nicoletta Riva | Walter Ageno | ... | Alberto Tosetto
  • Special Issue
  • - Volume 2015
  • - Article ID 738548
  • - Review Article

Budd-Chiari Syndrome in China: A Systematic Analysis of Epidemiological Features Based on the Chinese Literature Survey

Wei Zhang | Xun Qi | ... | Ke Xu
  • Special Issue
  • - Volume 2015
  • - Article ID 839875
  • - Review Article

Prevalence of Budd-Chiari Syndrome during Pregnancy or Puerperium: A Systematic Review and Meta-Analysis

Weirong Ren | Xiang Li | ... | Zhengyu Xu
  • Special Issue
  • - Volume 2015
  • - Article ID 121060
  • - Research Article

The Significance of Serum CA-125 Elevation in Chinese Patients with Primary Budd-Chiari Syndrome: A Multicenter Study

De-lei Cheng | Hao Xu | ... | Qing-qiao Zhang
  • Special Issue
  • - Volume 2015
  • - Article ID 245460
  • - Review Article

Prevalence of Splanchnic Vein Thrombosis in Pancreatitis: A Systematic Review and Meta-Analysis of Observational Studies

Wenda Xu | Xingshun Qi | ... | Xiaozhong Guo
  • Special Issue
  • - Volume 2014
  • - Article ID 292689
  • - Review Article

Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: A Meta-Analysis

Xingshun Qi | Ming Bai | ... | Daiming Fan
Gastroenterology Research and Practice
 Journal metrics
Acceptance rate25%
Submission to final decision63 days
Acceptance to publication29 days
CiteScore3.400
Impact Factor1.806
 Submit